Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Bringing antivenoms to Sub-Saharan Africa

To reduce unacceptably high death rates from snakebite envenomation, sub-Saharan Africa must adopt not only a new generation of multivalent biotech antivenoms, but also an infrastructure to deliver them.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1
Figure 2
Figure 3

References

  1. 1

    Chippaux, J-P. Venins de Serpent et Envenimations (IRD Editions, Col. Didactiques, Paris, 2002).

    Book  Google Scholar 

  2. 2

    Gutiérrez, J.M., Theakston, R.D.G. & Warrell, D.A. PLoS Med. 3, 727–731 (2006)

    Article  Google Scholar 

  3. 3

    Chippaux, J-P. Toxicon 36, 1503–1506 (1998).

    CAS  Article  Google Scholar 

  4. 4

    Chippaux, J-P. in Perspectives in Molecular Toxinology (ed. Ménez, A.) 457–472 (Wiley & Sons, London, 2002).

    Google Scholar 

  5. 5

    Lalloo, D.G. & Theakston, R.D.G. J. Toxicol. Clin. Toxicol. 41, 277–290 (2003).

    CAS  Article  Google Scholar 

  6. 6

    Chippaux, J.P. Bull. Soc. Pathol. Exot. 98, 263–268 (2005).

    CAS  PubMed  Google Scholar 

  7. 7

    Theakston, R.D.G., Warrell, D.A. & Griffiths, E. Toxicon 41, 541–557 (2003).

    CAS  Article  Google Scholar 

  8. 8

    Chippaux, J.P., Stock, R.P. & Alagón, A. Toxicon 46, 115–118 (2005).

    CAS  Article  Google Scholar 

  9. 9

    Chippaux, J.P., Lang, J., Amadi-Eddine, S., Fagot, P. & Le Mener, V. Am. J. Trop. Med. Hyg. 61, 1017–1018 (1999).

    CAS  Article  Google Scholar 

  10. 10

    Nkinin, S.W. et al. Bull. Soc. Pathol. Exot. 90, 277–281 (1997).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Many people have contributed to this initiative and continue to do so. From the Republic of Benin, we wish to warmly acknowledge the absolutely essential work of all the health personnel involved in the ongoing clinical trials. From the Instituto Bioclon (Mexico City), the makers of Africamyn, for their consistent support in every imaginable way: J. López de Silanes, J. Paniagua-Solís, J. Estévez and others; from the Instituto de Biotecnología, B. Ramos-Cerrillo and Adolfo de Roodt. From Latoxan (France), Y. Doljansky and F. Principaud. And to all the participants at the 2ème Colloque sur les envenimations en Afrique, Cotonou, 2004, who have contributed, and continue to contribute, invaluable epidemiological data for quite a few West and Central African countries.

Author information

Affiliations

Authors

Ethics declarations

Competing interests

We have a research grant from Instituto Biolclon, S.A. de C.V. (a Mexican producer of antivenoms for developing snake antivenom to be used in Africa. R.P.S. and A.A. also receive consultation fees from Bioclon.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Stock, R., Massougbodji, A., Alagón, A. et al. Bringing antivenoms to Sub-Saharan Africa. Nat Biotechnol 25, 173–177 (2007). https://doi.org/10.1038/nbt0207-173

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing